基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 化工产品目录 生物化工 抗体 一抗 多抗 SLC22A17抗体 SLC22A17抗体
  • SLC22A17抗体;SLC22A17 Antibody—艾普蒂
  • SLC22A17抗体;SLC22A17 Antibody—艾普蒂
  • SLC22A17抗体;SLC22A17 Antibody—艾普蒂

1/3

SLC22A17抗体;SLC22A17 Antibody—艾普蒂

Rabbit Polyclonal SLC22A17 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期：2025-05-25

上海切尔齐生物科技有限公司

非会员
联系人：周***
电话：027***
手机：180***
邮箱：nuo***

产品详情:

中文名称：
SLC22A17抗体
英文名称：
Rabbit Polyclonal SLC22A17 Antibody
品牌：
艾普蒂
产地：
武汉
保存条件：
Stored at -20°C for 6012 year. Avoid repeated freeze / thaw cycles.
产品类别：
抗体
重组：
否
应用：
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性：
Human,Mouse,Rat
宿主：
Rabbit
偶联物：
无
靶点：
SLC22A17

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/25-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesBOCT, BOIT, 24p3R, NGALR, hBOIT, NGALR2, NGALR3
WB Predicted band size56 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human SLC22A17
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 10%SDS-PAGE, Lysate: 40 μg, Lane: Human esophagus cancer tissue, Primary antibody: P11347(SLC22A17 Antibody) at dilution 1/600, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 20 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P11347(SLC22A17 Antibody) at dilution 1/30. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using P11347(SLC22A17 Antibody) at dilution 1/30. (Original magnification: ×200)    


           

参考文献

以下是3篇与SLC22A17抗体相关的文献摘要信息：

1. **"SLC22A17 mediates the uptake of iron-bound lipocalin-2 in human leukemia cells"**

- **作者**: Schmitt R. et al.

- **摘要**: 研究揭示了SLC22A17作为脂质运载蛋白-2(LCN2)的受体，在急性髓系白血病细胞中介导铁转运的功能。该文献利用特异性抗体进行Western blot和免疫荧光实验，证实了SLC22A17在细胞膜上的定位及其与LCN2的结合。

2. **"SLC22A17 expression is epigenetically regulated in acute myeloid leukemia"**

- **作者**: Asano M. et al.

- **摘要**: 分析了SLC22A17在急性髓系白血病(AML)中的表观遗传调控机制，发现其表达受DNA甲基化影响。通过抗体的免疫组化实验，发现SLC22A17低表达与AML患者不良预后相关。

3. **"SLC22A17 modulates cellular iron metabolism through interaction with transferrin receptor 1"**

- **作者**: Yoshikawa M. et al.

- **摘要**: 研究提出SLC22A17通过与转铁蛋白受体1(TfR1)相互作用调节细胞铁代谢。利用抗体的共免疫沉淀技术验证了两者的结合，并发现SLC22A17敲除导致细胞内铁稳态失衡。

4. **"Lipocalin-2 receptor (SLC22A17) is required for renal differentiation and regulates iron trafficking"**

- **作者**: Schmidt-Ott K.M. et al.

- **摘要**: 报道了SLC22A17在肾脏发育和铁运输中的作用，通过抗体阻断实验证明其在肾小管细胞中对脂质运载蛋白-2介导的铁摄取至关重要。

这些文献均涉及SLC22A17抗体的实验应用(如蛋白定位、表达分析或功能研究)，并聚焦于其在铁代谢、癌症或肾脏疾病中的生物学意义。

       

背景信息

The SLC22A17 antibody is a research tool targeting the solute carrier family 22 member 17 (SLC22A17), a transmembrane protein initially identified as a receptor for lipocalin-2 (LCN2). SLC22A17. also known as NGAL receptor or 24p3R, belongs to the SLC22 transporter family but functions primarily in ligand binding and signaling rather than solute transport. Structurally, it contains 12 transmembrane domains and localizes to plasma or endosomal/lysosomal membranes. It plays roles in iron homeostasis by mediating cellular uptake of iron-bound lipocalin-2. apoptosis regulation, and innate immunity. SLC22A17 is expressed in kidney, liver, immune cells, and certain cancers. Its dysregulation is linked to tumor progression, chemoresistance, and kidney diseases.

Antibodies against SLC22A17 are used to study its expression patterns, subcellular localization, and interactions in various pathologies. They enable detection via Western blotting, immunohistochemistry, and immunofluorescence. Specificity validation (e.g., knockout controls) is critical due to potential cross-reactivity with other SLC22 family members. Current research focuses on its dual roles in cancer (pro-survival vs. apoptotic signals) and its interplay with iron metabolism. Challenges include distinguishing between isoforms and clarifying context-dependent signaling mechanisms. These antibodies support investigations into therapeutic targeting of SLC22A17-related pathways in inflammation, fibrosis, and oncology.

       
SLC22A17抗体;SLC22A17;SLC22A17 Antibody;

公司简介

生物技术有限公司

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ￥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,植物生物技术,细胞培养,蛋白组学

SLC22A17抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥（北京）生物科技有限公司 VIP
  • 2026-03-02
  • 询价
内容声明
official 进入官方账号
拨打电话 立即询价